These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2084078)

  • 21. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.
    Walker UA; Tyndall A; Czirják L; Denton CP; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 Jun; 68(6):856-62. PubMed ID: 18625615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between occupational risk factors and severity markers of systemic sclerosis.
    Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
    J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological study of renal involvement in patients with systemic sclerosis.
    Zeng X; Chen J; Dong Y
    Chin Med J (Engl); 1998 Mar; 111(3):224-7. PubMed ID: 10374421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High incidence of celiac disease in patients with systemic sclerosis.
    Rosato E; De Nitto D; Rossi C; Libanori V; Donato G; Di Tola M; Pisarri S; Salsano F; Picarelli A
    J Rheumatol; 2009 May; 36(5):965-9. PubMed ID: 19332639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
    Aoyama K; Nagai Y; Endo Y; Ishikawa O
    J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary-renal syndrome in systemic sclerosis.
    Bar J; Ehrenfeld M; Rozenman J; Perelman M; Sidi Y; Gur H
    Semin Arthritis Rheum; 2001 Jun; 30(6):403-10. PubMed ID: 11404823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.
    Negi VS; Tripathy NK; Misra R; Nityanand S
    J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of systemic sclerosis in a large US managed care population.
    Furst DE; Fernandes AW; Iorga SR; Greth W; Bancroft T
    J Rheumatol; 2012 Apr; 39(4):784-6. PubMed ID: 22382343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement.
    Nishimagi E; Tochimoto A; Kawaguchi Y; Satoh T; Kuwana M; Takagi K; Ichida H; Kanno T; Soejima M; Baba S; Kamatani N; Hara M
    J Rheumatol; 2007 Oct; 34(10):2050-5. PubMed ID: 17924608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Scleroderma in a hospital setting in Togo].
    Pitche P; Amanga Y; Koumouvi K; Oniankitan O; Mijiyawa M; Tchangaï-Walla K
    Med Trop (Mars); 1998; 58(1):65-8. PubMed ID: 9718559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic scleroderma: a spatiotemporal clustering.
    Englert H; Joyner E; Bade R; Thompson M; Morris D; Chambers P; Carroll G; Manolios N
    Intern Med J; 2005 Apr; 35(4):228-33. PubMed ID: 15836501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
    Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.